Mitral valve repair failure: patient profile outweighs technique

Determinants of mitral repair failure: technique or biological background?

While degenerative mitral valve repair is the gold standard, managing late failures remains a challenge for the cardiac surgeon. Why does a repaired valve progress to recurrent prolapse rather than progressive stenosis? To address this major clinical question, this study analyzed a cohort of 121 patients who underwent reintervention between January 2010 and June 2026. The objective was to dissociate the impact of intrinsic patient characteristics from that of initial technical choices on the anatomical mechanisms of failure.

The tested hypothesis relies on the potential influence of reconstruction strategies (resection vs. leaflet preservation, use of ePTFE neochords, edge-to-edge technique, or annuloplasty ring size) against individual risk factors. The authors sought to determine whether the mode of failure—stenosis or recurrent prolapse—is the direct consequence of biomechanics imposed by the surgeon or the result of a biological process specific to the patient, such as tissue remodeling related to age or sex.

Methodology: A retrospective look at 16 years of practice

This study is based on a single-center retrospective review spanning from January 2010 to June 2026. The researchers analyzed a cohort of 121 adult patients who required surgical reintervention after an initial mitral valve repair for degenerative disease. To ensure data accuracy and limit classification bias, inclusion required exhaustive operative documentation, both for the index procedure and for the detailed intraoperative findings during reintervention.

The protocol consisted of comparing initial reconstruction techniques—notably leaflet preservation or resection, implantation of ePTFE neochords, the edge-to-edge technique, and ring size—with the identified anatomical mechanisms of failure. These mechanisms were classified into several categories:

• Recurrence of valvular prolapse;
• Development of mitral stenosis;
• Complications related to annuloplasty;
• Structural alterations (leaflet perforations or retractions).

The originality of the statistical analysis lies in the use of a competing-risks framework. This methodological approach is crucial: it allows for treating recurrent prolapse and mitral stenosis as mutually exclusive events, thus refining the identification of predictive factors via multivariate analysis crossing patient characteristics and the technical specificities of the initial repair.

Failure mechanisms: prolapse in the lead

Analysis of the 121 patients in the cohort reveals marked heterogeneity in the failure modes of initial repairs. Recurrent valvular prolapse is the most frequent mechanism, identified in 71.6% of patients presenting with mitral regurgitation during reintervention. Mitral stenosis constitutes the second major mode of failure, affecting 27.3% of all cases.

Impact of initial surgical techniques

A major finding of this study is the absence of a significant statistical link between the technical choices of the first intervention and the anatomical mechanism of failure. After adjustment, none of the recorded surgical variables showed a predominant influence on the mode of dysfunction:

Patient profile: a major determinant of outcome

While the surgical technique appears neutral in this reintervention cohort, the intrinsic characteristics of the patients weigh more heavily on the mode of failure. Multivariate analysis identifies distinct predictors:

• Advanced age at initial intervention: Independently associated with recurrence of prolapse.
• Young age and female sex: Independent predictors of the development of mitral stenosis.

These data suggest that, in patients requiring reintervention, the mechanism of failure is intimately linked to the biological background and patient characteristics, rather than the initial reconstruction strategy adopted.

Analysis of failure trajectories: the host outweighs the technique

The results of this study on 121 patients suggest that the anatomical fate of a failed mitral repair depends more on the patient profile than on the initial surgical strategy. While recurrent prolapse remains the predominant mechanism (71.6%), the prevalence of mitral stenosis (27.3%) highlights an important pathological duality. Clinically, the fact that neither the choice of resection, nor the use of ePTFE neochords, nor the ring size is statistically associated with a specific mechanism is a major finding: the technique likely influences overall durability, but it does not seem to dictate the nature of the failure once it has begun.

The independent association between advanced age and recurrent prolapse, versus the "young age and female sex" duo predicting stenosis, points toward distinct tissue remodeling processes. These observations corroborate the idea that failure is not a simple recurrence of the initial disease, but a spectrum of active pathological pathways, potentially linked to the host's biological response to prosthetic materials or induced biomechanical modifications.

However, this study has intrinsic limitations. By focusing exclusively on a reintervention population, it does not allow for the assessment of the true incidence of these complications within the total operated population (absence of a denominator). Furthermore, its retrospective nature and the use of preoperative echocardiographic criteria rather than intraoperative hemodynamic criteria to define stenosis require cautious interpretation. Nevertheless, these data argue for increased vigilance and differentiated echocardiographic follow-up, particularly attentive to progressive stenosis in young female patients after degenerative valve surgery.

Study summary

The analysis of reinterventions shows that recurrent prolapse dominates the mechanisms of failure (71.6%), ahead of mitral stenosis (27.3%). While initial technical choices (resection, neochords, ring size) do not influence the mode of failure, the patient profile is decisive: advanced age predicts prolapse, while female sex and young age favor stenosis.

Concretely, for the practitioner:

• Target surveillance: Intensify echocardiographic follow-up in young female patients to detect early mitral stenosis, as this profile is biologically at higher risk of obstructive remodeling.
• Put technical impact into perspective: The choice between resection or preservation does not dictate the future mode of failure; anatomical evolution seems more linked to host biology than to the surgical strategy employed.
• Adjust clinical alert: In elderly subjects, remain vigilant regarding recurrent prolapse, the predominant failure mechanism requiring proactive management.

Technical glossary of the study

Recurrent valve prolapse: Principal anatomical mechanism of failure identified in this study (71.6% of mitral regurgitation cases), characterizing the return of a leaflet coaptation defect after the initial surgery.

Mitral stenosis: Obstruction of valvular flow observed by preoperative echocardiographic evaluation in 27.3% of the cohort patients, independently predicted by female sex and young age at the time of the initial intervention.

Competing-risks framework: Statistical analysis structure used by the authors to address mutually exclusive clinical outcomes, allowing for the distinction between risk factors for prolapse and those for stenosis.

Index repair: Refers to the initial degenerative mitral valve repair surgery, whose technical variables (ring size, type of resection) were analyzed to determine their influence on long-term failure.

ePTFE neochords: Leaflet preservation technique using expanded polytetrafluoroethylene sutures, the use of which during the initial repair showed no significant association with a specific failure mechanism in this series.

Edge-to-edge repair: Surgical technique consisting of suturing the prolapsing leaflet areas, evaluated here as one of the technical characteristics of the initial repair potentially linked to valve durability.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims any liability for the use of this information. This document is not intended for patients or the general public.